Citations for
1NXNL1, NXNL2
Thioredoxin rod-derived cone viability factor protects against photooxidative retinal damage.
Elachouri G, Lee-Rivera I, Clérin E, Argentini M, Fridlich R, Blond F, Ferracane V, Yang Y, Raffelsberger W, Wan J, Bennett J, Sahel JA, Zack DJ, Léveillard T.
Free Radic Biol Med 81:22-9. doi: 10.1016/j.freeradbiomed.2015.01.003. Epub 2015 Jan 14. 2015
2NXNL1
Viral-mediated RdCVF and RdCVFL expression protects cone and rod photoreceptors in retinal degeneration.
Byrne LC, Dalkara D, Luna G, Fisher SK, Clérin E, Sahel JA, Léveillard T, Flannery JG.
J Clin Invest 125(1):105-16. doi: 10.1172/JCI65654. Epub 2014 Nov 21. 2015
3NXNL1, NXNL2
Transcriptional regulation of nucleoredoxin-like genes takes place on a daily basis in the retina and pineal gland of rats.
Wolloscheck T, Kunst S, Kelleher DK, Spessert R.
Vis Neurosci 32:E002. doi: 10.1017/S0952523814000352. 2015
4NXNL1
Therapeutic strategy for handling inherited retinal degenerations in a gene-independent manner using rod-derived cone viability factors.
Léveillard T, Fridlich R, Clérin E, Aït-Ali N, Millet-Puel G, Jaillard C, Yang Y, Zack D, van-Dorsselaer A, Sahel JA.
C R Biol 337(3):207-13. doi: 10.1016/j.crvi.2013.12.002. Epub 2014 Feb 20. Review. 2014
5NXNL1
Optimal control in the treatment of retinitis pigmentosa.
Camacho ET, Melara LA, Villalobos MC, Wirkus S.
Bull Math Biol 76(2):292-313. doi: 10.1007/s11538-013-9919-1. Epub 2013 Nov 21. 2014
6NXNL1
Functional rescue of cone photoreceptors in retinitis pigmentosa.
Sahel JA, Léveillard T, Picaud S, Dalkara D, Marazova K, Safran A, Paques M, Duebel J, Roska B, Mohand-Said S.
Graefes Arch Clin Exp Ophthalmol 251(7):1669-77. doi: 10.1007/s00417-013-2314-7. Review. No abstract available. 2013
7NXNL1, NXNL2
Nxnl2 splicing results in dual functions in neuronal cell survival and maintenance of cell integrity.
Jaillard C, Mouret A, Niepon ML, Clérin E, Yang Y, Lee-Rivera I, Aït-Ali N, Millet-Puel G, Cronin T, Sedmak T, Raffelsberger W, Kinzel B, Trembleau A, Poch O, Bennett J, Wolfrum U, Lledo PM, Sahel JA, Léveillard T.
Hum Mol Genet 21(10):2298-311. doi: 10.1093/hmg/dds050. Epub 2012 Feb 15. 2012
8NXNL1, VSX2
The homeobox gene CHX10/VSX2 regulates RdCVF promoter activity in the inner retina.
Reichman S, Kalathur RK, Lambard S, Aït-Ali N, Yang Y, Lardenois A, Ripp R, Poch O, Zack DJ, Sahel JA, Léveillard T.
Hum Mol Genet 19(2):250-61. Epub 2009 Oct 20.PMID: 19843539 2010
9MSRA, NXNL1
TXNL6 is a novel oxidative stress-induced reducing system for methionine sulfoxide reductase a repair of α-crystallin and cytochrome C in the eye lens.
Brennan LA, Lee W, Kantorow M.
PLoS One 5(11):e15421. 2010
10FLII, NXN, NXNL1
Nucleoredoxin negatively regulates Toll-like receptor 4 signaling via recruitment of flightless-I to myeloid differentiation primary response gene (88).
Hayashi T, Funato Y, Terabayashi T, Morinaka A, Sakamoto R, Ichise H, Fukuda H, Yoshida N, Miki H.
J Biol Chem 285(24):18586-93. doi: 10.1074/jbc.M110.106468. Epub 2010 Apr 16. 2010
11NXNL1, NXNL2
Expression of rod-derived cone viability factor: dual role of CRX in regulating promoter activity and cell-type specificity.
Lambard S, Reichman S, Berlinicke C, Niepon ML, Goureau O, Sahel JA, Léveillard T, Zack DJ.
PLoS One 5(10):e13075. doi: 10.1371/journal.pone.0013075. 2010
12NXNL1
Thioredoxin-like 6 protects retinal cell line from photooxidative damage by upregulating NF-kappaB activity.
Wang XW, Tan BZ, Sun M, Ho B, Ding JL.
Free Radic Biol Med 45(3):336-44. Epub 2008 Apr 26.PMID: 18474255 2008
13NXNL1
Mapping of transcription start sites of human retina expressed genes.
Roni V, Carpio R, Wissinger B.
BMC Genomics 8:42.PMID: 17286855 2007
14NXNL1
Disease-associated variants of the rod-derived cone viability factor (RdCVF) in Leber congenital amaurosis. Rod-derived cone viability variants in LCA.
Hanein S, Perrault I, Gerber S, Dollfus H, Dufier JL, Feingold J, Munnich A, Bhattacharya S, Kaplan J, Sahel JA, Rozet JM, Leveillard T.
Adv Exp Med Biol 572:9-14. No abstract available. PMID: 17249548 2006
15NXNL1
Identification and characterization of rod-derived cone viability factor.
Leveillard T, Mohand-Said S, Lorentz O, Hicks D, Fintz AC, Clerin E, Simonutti M, Forster V, Cavusoglu N, Chalmel F, Dolle P, Poch O, Lambrou G, Sahel JA.
Nat Genet 36(7):755-9. Epub 2004 Jun 27. 2004